Personalized Medical Care & Dedicated International Patient Concierge

4.9 Patient Satisfaction

en-US

Medical Clinic LogoMedical ClinicHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesBefore & AfterReviewsAbout UsContact Us
GLP-1 Weight-Loss Injection

Body Contouring & Slimming · Needs Clinic Confirmation

GLP-1 Weight-Loss Injection

GLP-1 Weight-Loss Injection helps regulate appetite, reduce food intake, and support weight management under medical supervision.

Schedule a Consultation

GLP-1 Weight-Loss Injection

Woman in pink athletic wear posing with one hand on her waist beside a body fat illustration.

Medically reviewed by Dr. Lee Jung Hoon, Dr. Kim Sung Wook (board-certified dermatologists) and Dr. Choi Hang Seok (board-certified plastic surgeon), SeouLeaguer Dermatology, Seoul

GLP-1 Weight-Loss Injection is a prescription medication used to support weight management by acting on hormone pathways that regulate appetite, food intake, and satiety, offered as part of SeouLeaguer Dermatology's body-contouring specialty for patients seeking medically supervised weight management.

What Is GLP-1 Weight-Loss Injection?

Unlike the clinic's injectable or energy-based aesthetic treatments, this service is a systemic prescription medication rather than a localized procedure targeting a specific area of the body. GLP-1-based medications act on hormone pathways that regulate appetite, food intake, and satiety, supporting weight management by helping patients feel fuller and eat less over the course of continued treatment, rather than acting directly on fat cells or skin tissue in a treated area.

U.S. patients may seek medically supervised weight-management treatment that can provide appetite control and clinically meaningful weight reduction without surgery, often after having tried diet and exercise approaches on their own with limited or unsustained results.

Patients sometimes arrive at consultation expecting a single injection to produce an immediate, dramatic change, conflating this service with the clinic's localized aesthetic injectables. Clarifying this distinction early is part of the consultation's value: GLP-1 treatment is a prescribed medication taken on an ongoing schedule, with its effect building progressively over months of continued use and close medical supervision, not a one-time procedure with an immediate visible result in the way a filler or fat-dissolving injection might produce.

  • Mechanism: a prescription medication acting on hormone pathways that regulate appetite, food intake, and satiety, administered by subcutaneous injection according to a prescribed schedule.
  • Positioned for adults seeking medically supervised weight management who may benefit from GLP-1-based treatment, particularly those with overweight or obesity and/or weight-related health concerns.
  • No anesthesia is normally needed for the injection itself; the medication's effects are systemic rather than localized to an injection site.
  • Appetite effects may occur relatively early, but meaningful weight loss develops progressively over approximately three to four months of continued treatment.

How GLP-1 Weight-Loss Injection Compares to Other Options in This Specialty

Within this specialty, GLP-1 Weight-Loss Injection is fundamentally different from the clinic's other three services: Body Fat-Dissolving Injection, Skinny Leg Injection, and Body Skin Tightening all work locally on a specific treatment area through direct injection or energy delivery, while GLP-1 medication works systemically on the whole body's appetite-regulating hormone pathways and is not targeted at any single area of localized fat, leg bulk, or skin laxity. More broadly, alternatives include structured diet and physical-activity programs, other anti-obesity medications, and metabolic or bariatric surgery for appropriately selected patients. The most appropriate option depends on the patient's overall health profile, weight-related goals, and medical history, assessed directly by the physician rather than chosen based on which option sounds most convenient.

Who Performs GLP-1 Weight-Loss Injection at SeouLeaguer Dermatology

Dr. Lee Jung Hoon, board-certified dermatologist at SeouLeaguer Dermatology

Dr. Lee Jung Hoon

Dr. Choi Hang Seok, board-certified plastic surgeon at SeouLeaguer Dermatology

Dr. Choi Hang Seok

Dr. Kim Sung Wook, board-certified dermatologist at SeouLeaguer Dermatology

Dr. Kim Sung Wook

GLP-1 Weight-Loss Injection sits under SeouLeaguer Dermatology's own specialty grouping, where candidacy assessment and treatment planning are shared by the clinic's three specialists: Dr. Lee Jung Hoon (board-certified dermatologist, Chief Director, 24+ years of practice), Dr. Kim Sung Wook (board-certified dermatologist, 29+ years of experience, professor of dermatology at the Catholic University of Korea), and Dr. Choi Hang Seok (board-certified plastic surgeon, residency at Seoul St. Mary's Hospital, The Catholic University of Korea). For this service specifically, the physician reviews height, weight, BMI, weight history, medical conditions, medications and supplements, allergies, pregnancy plans, family history, previous weight-loss treatments, and relevant gastrointestinal or endocrine history, reflecting that this is a prescribed medical treatment rather than a localized aesthetic procedure.

Who Is a Good Candidate for GLP-1 Weight-Loss Injection?

  • Adults seeking medically supervised weight management who may benefit from GLP-1-based treatment, particularly those with overweight or obesity and/or weight-related health concerns.
  • Suitability depends on overall health, medical history, current medications, and the specific medication prescribed, assessed individually rather than assumed from the patient's stated weight-loss goal alone.
  • People who are pregnant, have a serious allergy to the prescribed medication, or have certain medical conditions that may make GLP-1-based treatment unsafe may not be suitable.
  • A medical assessment is needed to evaluate individual risks, medical history, and medication interactions before treatment begins.

What to Expect: Procedure, Recovery, and Results Timeline

Stage What typically happens
Consultation Medical history, weight history, medications, allergies, pregnancy plans, family history, and relevant gastrointestinal or endocrine history are reviewed for eligibility.
Medication selection The appropriate medication and starting dose are selected based on the individual assessment.
Administration The medication is administered by subcutaneous injection according to the prescribed schedule.
Duration Procedure time is about 15 to 30 minutes per visit, with 1 initial consultation and 3 to 4 follow-up visits generally planned.
Monitoring Tolerance, weight response, and adverse effects are monitored, with the dose adjusted gradually when clinically appropriate.
Recovery No conventional recovery period is required; patients can generally return to normal activities after the injection.
Results timeline Appetite effects may occur relatively early, but meaningful weight loss develops progressively over approximately three to four months.

Before treatment, patients provide a complete list of prescription medicines, over-the-counter medicines, supplements, allergies, medical conditions, previous weight-loss medications, and diabetes treatments. Aftercare involves following the prescribed dosing schedule and maintaining adequate fluid intake, nutrition, physical activity, and follow-up monitoring as recommended by the treating physician.

About 1 to 2 days is generally sufficient for the initial consultation and first administration, though GLP-1 treatment is inherently an ongoing medical program rather than a single visit, and patients living outside Korea need a clear plan for how subsequent doses, monitoring, and prescription continuity will be managed once they return home. This is a meaningfully different travel consideration than the clinic's single-session aesthetic treatments, and international patients are encouraged to discuss this directly at consultation before starting the medication.

Patients are also told plainly what to expect regarding the pace of results. Because meaningful weight loss develops progressively over months rather than appearing after a single dose, patients are advised against judging whether the medication is "working" based on the first few weeks alone, and are encouraged to maintain the prescribed schedule and follow-up monitoring throughout the expected multi-month timeline rather than discontinuing early based on an incomplete picture of the medication's effect.

Dose escalation is also discussed directly at the outset, since GLP-1 medications are generally started at a lower dose and increased gradually according to a prescribed schedule rather than beginning at the dose expected to produce the eventual full effect. This gradual approach is intended to allow the body to adjust and to reduce the likelihood or severity of gastrointestinal side effects, and patients are told that a dose increase partway through treatment is a planned part of the protocol rather than a sign that the initial dose was not working. The physician monitors tolerance at each visit before deciding whether to proceed with the next scheduled increase, and a patient experiencing more pronounced side effects than expected at a given dose may have the escalation schedule slowed rather than automatically advanced on the original timeline.

Follow-up visits also serve a broader purpose beyond simply recording weight change. At each visit, the physician reviews how the patient is tolerating the medication, whether any new medical conditions or medications have been introduced since the previous visit, and whether the patient's overall health profile still supports continuing at the current dose. This ongoing review is part of why GLP-1 treatment is structured as a series of visits rather than a single prescription handed over at the first consultation, and it is also why patients are asked to attend the scheduled follow-ups even once they feel the medication is working as expected, rather than treating the early visits as sufficient on their own.

Patients are also counseled on realistic expectations for how weight loss under GLP-1 treatment typically unfolds, since the rate and total amount of weight lost varies considerably between individuals depending on starting weight, adherence to the prescribed schedule, diet, activity level, and individual response to the medication. The clinic generally frames the medication as one component of a broader weight-management approach rather than a standalone solution that works independently of a patient's other habits, and discusses nutrition and physical activity alongside the medication itself rather than treating these as a separate, optional topic.

Longevity and Maintenance

Smiling woman in athletic wear holding a digital weighing scale against a white background.

Unlike the clinic's localized aesthetic treatments, GLP-1 Weight-Loss Injection's effect is tied directly to continued use of the medication rather than a one-time procedure whose result persists independently afterward. Weight-management benefits generally depend on the medication continuing to be taken as prescribed, with the physician determining, based on the patient's individual response and health profile, how long treatment should continue and whether a maintenance dose or an eventual tapering plan is appropriate.

Patients considering discontinuing the medication are encouraged to discuss this directly with the prescribing physician rather than stopping independently, since appetite and weight response can change once the medication is no longer being taken, and a planned approach to any dose adjustment or discontinuation is part of responsible medical supervision for this category of treatment. Because this service is fundamentally a prescribed medication rather than a cosmetic procedure, its "maintenance" question is better understood as an ongoing medical management decision made jointly between patient and physician, rather than a scheduled touch-up treatment of the kind used for some of the clinic's other body-contouring services.

International patients on an ongoing GLP-1 regimen are advised to plan for how prescription continuity, monitoring, and any necessary dose adjustments will be handled between visits to Korea, since a medication-based treatment of this kind depends on consistent medical oversight in a way that a single aesthetic procedure does not.

Patients who reach their weight-management goal and wish to stop the medication are generally guided through a planned reduction or discontinuation process rather than stopping abruptly, since appetite regulation can shift once the medication is withdrawn and a structured approach helps the physician monitor for any significant rebound in appetite or weight. Likewise, patients who wish to continue treatment for a longer-term maintenance phase after reaching an initial goal are assessed individually to determine whether ongoing treatment at a maintenance dose remains appropriate given their current health profile, since the considerations relevant at the start of treatment can change over months of continued use.

Combining GLP-1 Weight-Loss Injection with Other Treatments

  • GLP-1 medication may be combined with a reduced-calorie diet and increased physical activity as part of an overall weight-management plan.
  • This service is generally planned as part of a broader weight-management approach rather than combined directly with the clinic's localized aesthetic body-contouring services in the same visit.
  • Patients who achieve significant weight loss through GLP-1 treatment and subsequently have localized skin-laxity or contour concerns may discuss the clinic's other body-contouring services separately, once their weight has stabilized.
  • Any combination with other medications or treatments is planned individually by the treating physician based on diagnosis, goals and appropriate spacing between treatments.
  • Patients taking other medications or supplements are asked to disclose these fully, since interactions with a prescribed weight-management medication require specific medical review rather than general assumption.

Safety, Precision, and Clinic Standards

SeouLeaguer Dermatology is a Registered Medical Institution for Attracting Foreign Patients, certified by Korea's Ministry of Health and Welfare under the Act on Support for Overseas Expansion of Medical Services and Attraction of International Patients (Foreign Patient Attraction Registration No. M-2020-01-58584). Common adverse effects with semaglutide include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, and reflux-related symptoms, which the prescribing physician discusses specifically before treatment begins rather than presenting the medication as free of gastrointestinal effects.

Because GLP-1-based medications carry a distinct medical risk profile compared with the clinic's localized aesthetic treatments, the prescribing physician conducts a fuller medical assessment before treatment, reviewing medical history, current medications, and relevant gastrointestinal or endocrine history specifically rather than applying the same intake process used for an injectable filler or an RF skin-tightening session. People who are pregnant, have a serious allergy to the prescribed medication, or have certain medical conditions that may make GLP-1-based treatment unsafe are identified during this review and will have treatment declined or postponed where a contraindication applies.

Patients are also asked to disclose any history of other weight-loss medications, diabetes treatments, or gastrointestinal conditions, since these can meaningfully affect both the medication selected and the starting dose. Because GLP-1 medications interact with how the body regulates blood sugar and digestion, patients with diabetes or related conditions are assessed with particular care, and the treating physician may coordinate with the patient's other treating clinicians when relevant to ensure the weight-management medication is compatible with the patient's broader medical care.

Because this service is a prescribed medication rather than a one-time procedure, ongoing safety monitoring continues for as long as the patient remains on treatment, rather than being limited to the initial consultation. At each follow-up visit, the physician reassesses whether any new symptoms, medications, or health changes have emerged that could affect the suitability of continuing treatment at the current dose, and is prepared to pause or adjust the regimen if a concern arises. This ongoing-monitoring model distinguishes GLP-1 treatment from the clinic's single-session aesthetic services, where the main safety assessment happens once, before the procedure, rather than continuing across a period of months.

The Bottom Line

  • GLP-1 Weight-Loss Injection is a prescription medication supporting systemic weight management through appetite-regulating hormone pathways, not a localized aesthetic procedure.
  • Meaningful weight loss develops progressively over approximately three to four months of continued treatment, with ongoing monitoring throughout.
  • Suitability depends on a fuller medical assessment of health history, medications, and relevant gastrointestinal or endocrine history, with certain patients found unsuitable.
  • Candidacy, medication selection, and ongoing management are determined by the clinic's physicians together, based on each patient's overall health profile rather than a one-size-fits-all weight-loss protocol.

Frequently Asked Questions

Practitioner wearing pink gloves holding a syringe near a woman's abdomen during a body treatment.

**Am I a good candidate for GLP-1 Weight-Loss Injection?**Suitability depends on overall health, medical history, current medications, and the specific medication prescribed, assessed individually at consultation.**Is GLP-1 Weight-Loss Injection safe for American patients?**Yes, GLP-1 Weight-Loss Injection can be safe for eligible American patients following a full medical assessment that confirms there is no contraindication.**How long do I need to stay in Korea for this treatment?**About 1 to 2 days is generally sufficient for the initial consultation and first administration, though ongoing treatment and monitoring continue after returning home.**What does recovery look like after a GLP-1 injection?**No conventional recovery period is required, and patients can generally return to normal activities after the injection; meaningful weight loss develops progressively over three to four months.**Does SeouLeaguer Dermatology offer GLP-1 Weight-Loss Injection for international patients?**Yes, SeouLeaguer Dermatology offers GLP-1 Weight-Loss Injection for international patients, with care led by the clinic's board-certified doctors and consultations available in English.Can I start GLP-1 treatment if I have previously used another weight-loss medication? This is assessed individually at consultation, since previous weight-loss medications and their response inform the current medication and dose selected.

Book a Consultation at SeouLeaguer Dermatology

To find out whether GLP-1 Weight-Loss Injection fits your goals, book a consultation with SeouLeaguer Dermatology's dermatology and plastic surgery team in Gangnam, Seoul.

Disclaimer

This page is for general informational purposes only and does not constitute medical advice. Individual results vary, and a qualified physician should assess your suitability for any treatment described here before proceeding.

Sources & Further Reading on GLP-1 Weight-Loss Medication

  • FDA: Semaglutide Injection (Wegovy) Prescribing Information
  • FDA: Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
  • PubMed: GLP-1 Receptor Agonists in Obesity Treatment — A Review

Other Services

Explore additional treatments offered by our specialists.

View All
Pico Fraxel

Pico Fraxel

Pico Fraxel is a fractional laser treatment that delivers controlled laser energy to the skin to improve enlarged pores, uneven skin texture, acne-scar appearance, pigmentation, and overall skin quality.

Learn More

Learn More
ONDA Lifting (Microwave Facial Contouring)

ONDA Lifting (Microwave Facial Contouring)

ONDA Lifting uses targeted microwave energy to improve skin firmness and contours through personalized treatment settings.

Learn More

Learn More
CO2 Laser

CO2 Laser

CO2 laser treatment uses carbon dioxide laser energy to precisely remove or heat targeted layers of the skin.

Learn More

Learn More

Medical Clinic

Dedicated to evidence-based medical care, personalized treatment planning, and comprehensive support for local and international patients.

Treatments

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksBefore & AfterPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Medical Clinic. All rights reserved.

Individual clinical results may vary. Please consult a board-certified specialist.